These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 28428283)
1. Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection. Tummers WS; Warram JM; Tipirneni KE; Fengler J; Jacobs P; Shankar L; Henderson L; Ballard B; Pfefer TJ; Pogue BW; Weichert JP; Bouvet M; Sorger J; Contag CH; Frangioni JV; Tweedle MF; Basilion JP; Gambhir SS; Rosenthal EL Cancer Res; 2017 May; 77(9):2197-2206. PubMed ID: 28428283 [TBL] [Abstract][Full Text] [Related]
2. Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report. Rosenthal EL; Warram JM; de Boer E; Basilion JP; Biel MA; Bogyo M; Bouvet M; Brigman BE; Colson YL; DeMeester SR; Gurtner GC; Ishizawa T; Jacobs PM; Keereweer S; Liao JC; Nguyen QT; Olson JM; Paulsen KD; Rieves D; Sumer BD; Tweedle MF; Vahrmeijer AL; Weichert JP; Wilson BC; Zenn MR; Zinn KR; van Dam GM J Nucl Med; 2016 Jan; 57(1):144-50. PubMed ID: 26449839 [TBL] [Abstract][Full Text] [Related]
3. Review of clinical trials in intraoperative molecular imaging during cancer surgery. Lee JYK; Cho SS; Stummer W; Tanyi JL; Vahrmeijer AL; Rosenthal E; Smith B; Henderson E; Roberts DW; Lee A; Hadjipanayis CG; Bruce JN; Newman JG; Singhal S J Biomed Opt; 2019 Dec; 24(12):1-8. PubMed ID: 31808327 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence-guided surgery of cancer: applications, tools and perspectives. Low PS; Singhal S; Srinivasarao M Curr Opin Chem Biol; 2018 Aug; 45():64-72. PubMed ID: 29579618 [TBL] [Abstract][Full Text] [Related]
6. Design of Protease Activated Optical Contrast Agents That Exploit a Latent Lysosomotropic Effect for Use in Fluorescence-Guided Surgery. Ofori LO; Withana NP; Prestwood TR; Verdoes M; Brady JJ; Winslow MM; Sorger J; Bogyo M ACS Chem Biol; 2015 Sep; 10(9):1977-88. PubMed ID: 26039341 [TBL] [Abstract][Full Text] [Related]
7. Recommendations for reporting on emerging optical imaging agents to promote clinical approval. Tummers WS; Warram JM; van den Berg NS; Miller SE; Swijnenburg RJ; Vahrmeijer AL; Rosenthal EL Theranostics; 2018; 8(19):5336-5347. PubMed ID: 30555550 [TBL] [Abstract][Full Text] [Related]
8. Optical molecular imaging for tumor detection and image-guided surgery. Wang C; Wang Z; Zhao T; Li Y; Huang G; Sumer BD; Gao J Biomaterials; 2018 Mar; 157():62-75. PubMed ID: 29245052 [TBL] [Abstract][Full Text] [Related]
9. Optical innovations in surgery. de Boer E; Harlaar NJ; Taruttis A; Nagengast WB; Rosenthal EL; Ntziachristos V; van Dam GM Br J Surg; 2015 Jan; 102(2):e56-72. PubMed ID: 25627136 [TBL] [Abstract][Full Text] [Related]
10. Optical image-guided cancer surgery: challenges and limitations. Keereweer S; Van Driel PB; Snoeks TJ; Kerrebijn JD; Baatenburg de Jong RJ; Vahrmeijer AL; Sterenborg HJ; Löwik CW Clin Cancer Res; 2013 Jul; 19(14):3745-54. PubMed ID: 23674494 [TBL] [Abstract][Full Text] [Related]
11. An integrated widefield imaging and spectroscopy system for contrast-enhanced, image-guided resection of tumors. Mohs AM; Mancini MC; Provenzale JM; Saba CF; Cornell KK; Howerth EW; Nie S IEEE Trans Biomed Eng; 2015 May; 62(5):1416-24. PubMed ID: 25585410 [TBL] [Abstract][Full Text] [Related]
12. Molecular probes for fluorescence image-guided cancer surgery. Ito R; Kamiya M; Urano Y Curr Opin Chem Biol; 2022 Apr; 67():102112. PubMed ID: 35065431 [TBL] [Abstract][Full Text] [Related]
13. Perspective review of what is needed for molecular-specific fluorescence-guided surgery. Pogue BW; Rosenthal EL; Achilefu S; van Dam GM J Biomed Opt; 2018 Oct; 23(10):1-9. PubMed ID: 30291698 [TBL] [Abstract][Full Text] [Related]
14. Clinical translation and implementation of optical imaging agents for precision image-guided cancer surgery. Achterberg FB; Deken MM; Meijer RPJ; Mieog JSD; Burggraaf J; van de Velde CJH; Swijnenburg RJ; Vahrmeijer AL Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):332-339. PubMed ID: 32783112 [TBL] [Abstract][Full Text] [Related]
15. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals. Harapanhalli RS Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596 [TBL] [Abstract][Full Text] [Related]
16. American Society of Clinical Oncology policy statement: oversight of clinical research. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281 [TBL] [Abstract][Full Text] [Related]
17. Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration. Tibau A; Ocana A; Anguera G; Seruga B; Templeton AJ; Barnadas A; Amir E JAMA Oncol; 2016 Jun; 2(6):744-50. PubMed ID: 26940233 [TBL] [Abstract][Full Text] [Related]
18. Advanced Nanotechnology Leading the Way to Multimodal Imaging-Guided Precision Surgical Therapy. Wang C; Fan W; Zhang Z; Wen Y; Xiong L; Chen X Adv Mater; 2019 Dec; 31(49):e1904329. PubMed ID: 31538379 [TBL] [Abstract][Full Text] [Related]
19. [Antibodies, tools of choice for fluorescence-guided surgery]. Pèlegrin A; Gutowski M; Cailler F Med Sci (Paris); 2019 Dec; 35(12):1066-1071. PubMed ID: 31903919 [TBL] [Abstract][Full Text] [Related]
20. Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold System. Steinvil A; Rogers T; Torguson R; Waksman R JACC Cardiovasc Interv; 2016 Sep; 9(17):1757-64. PubMed ID: 27609249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]